Clinical Trial Update: Belimumab After Rituximab in Resistant Primary Juvenile SS [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating belimumab after rituximab in resistant primary Sjogren's syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Belimumab (belimumab)
• Rituximab (rituximab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Sjogren's Syndrome, Pediatric ALL | Phase 4 | Status: RECRUITING